Intellia Therapeutics, Inc. Business Operations Contracts & Agreements
7 Contracts & Agreements
- Collaboration Agreements (3 contracts)
- Indemnification Agreements (1)
- Management Agreements (1)
- Services Agreements (2)
- Third Amendment to License and Collaboration Agreement by and between Registrant and Regeneron Pharmaceuticals, Inc., dated September 29, 2023 (Filed With SEC on November 9, 2023)
- Letter Agreement (Second Amendment) to License and Collaboration Agreement by and between Registrant and Regeneron Pharmaceuticals, Inc., dated November 22, 2022 (Filed With SEC on November 9, 2023)
- Consent to Assignments, Licensing and Common Ownership and Invention Management Agreement dated December 15, 2016 by and between the Registrant, CRISPR Therapeutics AG, The... (Filed With SEC on February 24, 2022)
- Amendment No. 1, dated May 30, 2020, to the License and Collaboration Agreement, dated April 11, 2016, by and between Intellia Therapeutics, Inc. and Regeneron Pharmaceuticals, Inc (Filed With SEC on June 1, 2020)
- INDEMNIFICATION AGREEMENT (Filed With SEC on April 27, 2016)
- SERVICESAGREEMENT (Filed With SEC on April 19, 2016)
- SERVICESAGREEMENT (Filed With SEC on April 11, 2016)
